RxDoctor Payments Data

Debra Garrison, NP

Family · Florence, SCNPI 1427623008

Payments from drug & device makers

$1,328in general payments, 2019–2025

Across 75 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$143
  • AbbVie$126
  • GSK$118
  • Sage Therapeutics, LLC$106
  • Lilly USA, LLC$74
  • Sumitomo Pharma America, Inc.$72
  • plus $689 from 26 others

What the payments were for

  • Food & beverage$1,328100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,328 in reported general payments places this provider in the 70th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,150
Medicare patients
41
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$52,776
LinzessLinaclotide50$43,779
JardianceEmpagliflozin22$23,636
JanuviaSitagliptin Phosphate32$23,094
OzempicSemaglutide21$19,652
Janumet XrSitagliptin Phos/Metformin Hcl15$10,459
Breo ElliptaFluticasone/Vilanterol18$8,017
SymbicortBudesonide/Formoterol Fumarate25$6,827
Albuterol Sulfate HfaAlbuterol Sulfate203$5,174
NexlizetBempedoic Acid/Ezetimibe12$4,604
Sucralfate20$4,381
Atorvastatin Calcium548$2,874
Fluticasone Propionate204$2,370
Advair HfaFluticasone Propion/Salmeterol12$2,220
Allopurinol108$1,962

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$118$60,79281 claims
AbbVieLinzess, Synthroid$126$44,42564 claims
MerckJanuvia, Janumet Xr$27$33,55347 claims
Boehringer IngelheimJardiance$18$23,63622 claims
Novo NordiskOzempic$143$19,65221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,248 family providers in South Carolina.

Other family in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →